Steroid-Induced Osteonecrosis in Dermatology Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • Background: Steroid-induced osteonecrosis is unpredictable and highly morbid. Methods: MEDLINE (Ovid) and PubMed search for relevant literature. Results: Oral steroid doses typically considered to be associated with the condition are >20 mg of prednisone (or equivalent) per day or >2 g within a period of 2 to 3 months. Symptoms may be vague. Conclusions: Dermatologists must exercise a high degree of clinical suspicion and warn patients about steroid-related risks and conditions for follow-up.

publication date

  • July 2015